Study details strategy for boosting ranks of black HIV/AIDS researchersApril 01, 2009African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide. About 500,000 African Americans are now living with HIV/AIDS. Yet there are very few African American HIV/AIDS researchers, due to historical, social and other factors that prevent them from training in the biomedical, behavioral and social aspects of HIV/AIDS research. In response to the shortage, researchers from the UCLA Center for Culture, Trauma and Mental Health Disparities and the UCLA AIDS Institute have developed a series of recommendations that could reverse the trend and lead more African American researchers into the field. The recommendations are outlined in an article published in a supplement to the April issue of the American Journal of Public Health (available online at www.ajph.org/cgi/content/full/99/S1/S48). "The most effective behavior-change policies allow for individuals to be part of the solution and not the problem," said lead author Dr. Gail Wyatt, professor of psychiatry and biobehavioral sciences at the Semel Institute for Neuroscience and Human Behavior at UCLA. "We need African American experts who are at the forefront of HIV/AIDS prevention." The researchers have identified four institutional factors, as well as two individual factors, that limit the number of African Americans pursuing HIV/AIDS research. Institutional factors include limitation of early career decisions and a lack of exposure to research, research socialization and mentoring. For example, African American college students often don't receive research training early in their careers, so they may not be experienced in pulling together a team of strong research collaborators. In addition, some department chairs may think it is "too late" for doctoral graduates to move into a research career, and there are few senior African Americans to mentor and encourage a new generation of African American HIV/AIDS investigators. Compounding this situation are individual factors. Given the scarcity of role models, African American students may have negative perceptions about their own competence as HIV/AIDS investigators, and there is limited support for culturally congruent research. To boost the ranks of African American HIV/AIDS researchers, the study authors make the following seven recommendations to universities and other institutions of higher learning, and private and government funders of research and training: * Fund research that encourages partnerships with historically African American and minority-serving institutions, such as the National Medical Association and the Association of Black Psychologists, so that clinically trained professionals can participate in and learn more about HIV/AIDS research. * Provide for retraining of established researchers who wish to shift their focus to HIV/AIDS. * Continue to offer loan-repayment programs for graduate education. * Incorporate mentorships into graduate and professional training programs. * Encourage universities and training programs to recognize mentors whose students pursue HIV/AIDS research, and establish awards that recognize the work of African American investigators in the field. * Develop and use culturally congruent theories and measures in HIV/AIDS research. * Require training in cultural competence for federal staff, reviewers and mentors. "HIV/AIDS research conducted by highly trained African Americans should be the norm and not the exception," the authors conclude. "Such researchers add an important voice and level of expertise to HIV prevention that can only be enhanced by implementing programs to increase the representation of African American investigators in NIH-funded research. A concerted effort to remove barriers to funding and career trajectories to ensure that HIV/AIDS research addresses the most affected populations is needed." University of California - Los Angeles |
|||||||||||||||||||||
| Related HIV Current Events and HIV News Articles U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Indiana U. at APHA: Studies about why men and women use lubricants during sex An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex. New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. Magnetic nanoparticles to simultaneously diagnose, monitor and treat Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade. Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. Hepatitis B does not increase risk for pancreatic cancer A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor. Cell phones become handheld tools for global development Mobile phones are on the verge of becoming powerful tools to collect data on many issues, ranging from global health to the environment. Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas. Will genomics help prevent the next pandemic? This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||